SNY
Sanofi
Stock
$39.92−0.75 (−1.84%)Close Oct 2, 2026
Balance sheet
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | €7.7B | €7.4B | €8.7B | €12.7B | €10.1B | €13.9B | €9.4B | €6.9B | €10.3B | €10.3B | €9.1B |
| Inventory | €10.2B | €9.4B | €9.7B | €9.0B | €8.7B | €8.4B | €8.0B | €7.5B | €6.8B | €6.9B | €6.5B |
| Current assets | €31.0B | €42.6B | €30.7B | €34.1B | — | — | — | — | — | — | — |
| Goodwill | €41.3B | €43.4B | €49.4B | €49.9B | €48.1B | €44.4B | €44.5B | €44.2B | €40.3B | €40.3B | €39.6B |
| Intangible assets | €26.3B | €22.6B | €24.3B | €21.6B | €21.4B | €18.3B | €16.5B | €21.9B | €13.1B | €10.9B | €12.0B |
| Total assets | €126.8B | €132.8B | €126.5B | €126.7B | €120.2B | €114.4B | €112.6B | €111.4B | €99.8B | €104.7B | €102.3B |
| Current liabilities | €28.3B | €29.2B | €24.2B | €24.0B | — | — | — | — | — | — | — |
| Long-term debt | €14.2B | €11.8B | €14.3B | €14.9B | €17.1B | €19.7B | €20.1B | €22.0B | €14.3B | €16.8B | €13.1B |
| Total liabilities | €55.1B | €54.9B | €52.1B | €51.6B | €51.2B | €51.2B | €53.4B | €52.4B | €41.6B | €47.0B | €44.1B |
| Shareholders' equity | €71.4B | €77.5B | €74.0B | €74.8B | €68.7B | €63.1B | €59.1B | €58.9B | €58.1B | €57.6B | €58.0B |
| Shares outstanding | 1.22B | 1.26B | 1.26B | 1.26B | 1.26B | 1.25B | 1.25B | 1.25B | 1.25B | — | — |
| Current ratio | 1.09 | 1.46 | 1.27 | 1.42 | — | — | — | — | — | — | — |